全文获取类型
收费全文 | 875篇 |
免费 | 115篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 48篇 |
妇产科学 | 16篇 |
基础医学 | 127篇 |
口腔科学 | 24篇 |
临床医学 | 146篇 |
内科学 | 171篇 |
皮肤病学 | 39篇 |
神经病学 | 21篇 |
特种医学 | 91篇 |
外科学 | 86篇 |
综合类 | 28篇 |
预防医学 | 101篇 |
眼科学 | 3篇 |
药学 | 66篇 |
肿瘤学 | 35篇 |
出版年
2023年 | 7篇 |
2021年 | 6篇 |
2019年 | 14篇 |
2018年 | 13篇 |
2017年 | 9篇 |
2016年 | 11篇 |
2015年 | 17篇 |
2014年 | 11篇 |
2013年 | 29篇 |
2012年 | 20篇 |
2011年 | 23篇 |
2010年 | 20篇 |
2009年 | 24篇 |
2008年 | 25篇 |
2007年 | 45篇 |
2006年 | 32篇 |
2005年 | 36篇 |
2004年 | 30篇 |
2003年 | 26篇 |
2002年 | 20篇 |
2001年 | 34篇 |
2000年 | 15篇 |
1999年 | 29篇 |
1998年 | 25篇 |
1997年 | 26篇 |
1996年 | 36篇 |
1995年 | 17篇 |
1994年 | 25篇 |
1993年 | 12篇 |
1992年 | 27篇 |
1991年 | 26篇 |
1990年 | 21篇 |
1989年 | 31篇 |
1988年 | 34篇 |
1987年 | 26篇 |
1986年 | 22篇 |
1985年 | 22篇 |
1984年 | 17篇 |
1983年 | 21篇 |
1982年 | 10篇 |
1981年 | 12篇 |
1980年 | 8篇 |
1979年 | 12篇 |
1978年 | 6篇 |
1977年 | 14篇 |
1976年 | 7篇 |
1975年 | 7篇 |
1974年 | 10篇 |
1973年 | 6篇 |
1971年 | 6篇 |
排序方式: 共有1013条查询结果,搜索用时 15 毫秒
181.
Joshua D. Smith Andrew C. Birkeland Andrew J. Rosko Rebecca C. Hoesli Susan K. Foltin Paul Swiecicki Michelle Mierzwa Steven B. Chinn Andrew G. Shuman Kelly M. Malloy Keith A. Casper Scott A. McLean Gregory T. Wolf Carol R. Bradford Mark E. Prince John Chad Brenner Matthew E. Spector 《Head & neck》2019,41(2):423-428
182.
This experimental study determined if a "report card-like" oral health action plan was effective in improving oral health behaviors in a sample of 69 patients, ages 1 to 6 years. Participants were divided randomly into control and intervention groups. Data collected included dmft, plaque score, Streptococcus mutans levels and oral health behaviors. Participants in the intervention group received an oral health action plan that included: 1. child's current caries-risk status; 2. identification issues of concern; and 3. one "goal" to improve on for the next visit. All participants returned after two months for follow-up examination and data collection. 相似文献
183.
184.
185.
186.
Kirsty Boyd Bruce Mason Marilyn Kendall Stephen Barclay David Chinn Keri Thomas Aziz Sheikh Scott A Murray 《The British journal of general practice》2010,60(581):e449-e458
Background
Advance care planning is being promoted as a central component of end-of-life policies in many developed countries, but there is concern that professionals find its implementation challenging.Aim
To assess the feasibility of implementing advance care planning in UK primary care.Design of study
Mixed methods evaluation of a pilot educational intervention.Setting
Four general practices in south-east Scotland.Method
Interviews with 20 GPs and eight community nurses before and after a practice-based workshop; this was followed by telephone interviews with nine other GPs with a special interest in palliative care from across the UK.Results
End-of-life care planning for patients typically starts as an urgent response to clear evidence of a short prognosis, and aims to achieve a ‘good death’. Findings suggest that there were multiple barriers to earlier planning: prognostic uncertainty; limited collaboration with secondary care; a desire to maintain hope; and resistance to any kind of ‘tick-box’ approach. Following the workshop, participants'' knowledge and skills were enhanced but there was little evidence of more proactive planning. GPs from other parts of the UK described confusion over terminology and were concerned about the difficulties of implementing inflexible, policy-driven care.Conclusion
A clear divide was found between UK policy directives and delivery of end-of-life care in the community that educational interventions targeting primary care professionals are unlikely to address. Advance care planning has the potential to promote autonomy and shared decision making about end-of-life care, but this will require a significant shift in attitudes. 相似文献187.
188.
Holland WS Tepper CG Pietri JE Chinn DC Gandara DR Mack PC Lara PN 《Cancer chemotherapy and pharmacology》2012,69(1):185-194
Purpose
Inhibition of the mammalian target of rapamycin (mTOR), a regulator of hypoxia inducible factor (HIF), is an established therapy for advanced renal cell cancer (RCC). Inhibition of mTOR results in compensatory AKT activation, a likely resistance mechanism. We evaluated whether addition of the Akt inhibitor perifosine to the mTOR inhibitor rapamycin would synergistically inhibit RCC. 相似文献189.
190.